RAD51/geminin/γH2AX immunohistochemical expression predicts platinum-based chemotherapy response in ovarian high-grade serous carcinoma.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of gynecologic oncology"
DOI: 10.3802/jgo.2023.34.e45
Abstract: OBJECTIVE The RAD51 assay is a recently developed functional assay for homologous recombination deficiency (HRD) that reflects real-time HRD status. We aimed to identify the applicability and predictive value of RAD51 immunohistochemical expression in pre-… read more here.
Keywords: rad51 status; immunohistochemical expression; status; group ... See more keywords